336 related articles for article (PubMed ID: 23758330)
1. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
Moscarelli L; Caroti L; Antognoli G; Zanazzi M; Di Maria L; Carta P; Minetti E
Clin Transplant; 2013; 27(4):546-54. PubMed ID: 23758330
[TBL] [Abstract][Full Text] [Related]
2. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study.
Sood P; Senanayake S; Sujeet K; Medipalli R; Zhu YR; Johnson CP; Hariharan S
Transplantation; 2012 Oct; 94(8):814-21. PubMed ID: 23018881
[TBL] [Abstract][Full Text] [Related]
3. Role of BK virus infection in end-stage renal disease patients waiting for kidney transplantation--viral replication dynamics from pre- to post-transplant.
Mitterhofer AP; Tinti F; Pietropaolo V; Umbro I; Anzivino E; Bellizzi A; Zavatto A; Poli L; Berloco PB; Taliani G
Clin Transplant; 2014 Mar; 28(3):299-306. PubMed ID: 24506672
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center.
Mindlova M; Boucek P; Saudek F; Skibova J; Jedinakova T; Lipar K; Adamec M; Hirsch HH
Clin Transplant; 2012; 26(2):267-74. PubMed ID: 21854452
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.
Hirsch HH; Knowles W; Dickenmann M; Passweg J; Klimkait T; Mihatsch MJ; Steiger J
N Engl J Med; 2002 Aug; 347(7):488-96. PubMed ID: 12181403
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
7. Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.
Belliere J; Kamar N; Mengelle C; Allal A; Sallusto F; Doumerc N; Game X; Congy-Jolivet N; Esposito L; Debiol B; Rostaing L
Transpl Int; 2016 Mar; 29(3):315-22. PubMed ID: 26575959
[TBL] [Abstract][Full Text] [Related]
8. Increased gene expression of TGF-β in peripheral blood mononuclear cells from renal transplant patients with polyomavirus BK viremia.
Yin WY; Lee MC; Huang HB; Lu MC
Clin Transplant; 2016 Apr; 30(4):393-8. PubMed ID: 26783039
[TBL] [Abstract][Full Text] [Related]
9. Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique.
Herman J; Van Ranst M; Snoeck R; Beuselinck K; Lerut E; Van Damme-Lombaerts R
Pediatr Transplant; 2004 Oct; 8(5):485-92. PubMed ID: 15367285
[TBL] [Abstract][Full Text] [Related]
10. Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy.
Radtke J; Dietze N; Fischer L; Achilles EG; Li J; Scheidat S; Thaiss F; Nashan B; Koch M
Transpl Infect Dis; 2016 Dec; 18(6):850-855. PubMed ID: 27639176
[TBL] [Abstract][Full Text] [Related]
11. Observations on the use of cidofovir for BK virus infection in renal transplantation.
Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
[TBL] [Abstract][Full Text] [Related]
12. Prospective monitoring of BK virus replication in renal transplant recipients.
Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
[TBL] [Abstract][Full Text] [Related]
13. BK virus in liver transplant recipients: a prospective study.
Loeches B; Valerio M; Pérez M; Bañares R; Ledesma J; Fogeda M; Salcedo M; Rincón D; Bouza E; Muñoz P;
Transplant Proc; 2009 Apr; 41(3):1033-7. PubMed ID: 19376419
[TBL] [Abstract][Full Text] [Related]
14. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
15. Systematic screening of BK virus by real-time PCR prevents BK virus associated nephropathy in renal transplant recipients.
Hammarin AL; Öqvist B; Wahlgren J; Falk KI
J Med Virol; 2011 Nov; 83(11):1959-65. PubMed ID: 21915871
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.
Gabardi S; Townsend K; Martin ST; Chandraker A
Transpl Infect Dis; 2013 Aug; 15(4):361-8. PubMed ID: 23647907
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, Risk Factors, Treatment, and Overall Impact of BK Viremia on Kidney Transplantation.
Malik O; Saleh S; Suleiman B; Ashqar B; Maibam A; Yaseen M; Elrefaei A; Hines A; Cornea V; El-Husseini A; Mei X; Gedaly R; Castellanos AL; Waid T
Transplant Proc; 2019; 51(6):1801-1809. PubMed ID: 31399166
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
